Microbot Medical
MBOT
28 hedge funds and large institutions have $3.36M invested in Microbot Medical in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.
188% more call options, than puts
Call options by funds: $23K | Put options by funds: $8K
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
14% more capital invested
Capital invested by funds: $2.94M → $3.36M (+$420K)
3% less funds holding
Funds holding: 29 → 28 (-1)
7.38% less ownership
Funds ownership: 17.95% → 10.56% (-7.4%)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$135K |
| 2 |
Bank of New York Mellon
New York
|
+$74.8K |
| 3 |
HH
Hilltop Holdings
Dallas,
Texas
|
+$38.2K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$25.1K |
| 5 |
BCMLT
Beacon Capital Management LLC (Tennessee)
Franklin,
Tennessee
|
+$12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$430K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$112K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$48.3K |
| 4 |
BlackRock
New York
|
-$29.5K |
| 5 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$21K |
MBOT Hedge Fund Activity: Q2 2023 in Review
28 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2023, worth a combined $3.36M — up 14% from $2.94M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of MBOT and 4 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 8 added.
The largest buyer was Renaissance Technologies, adding an estimated $135K. The largest seller was Armistice Capital, cutting an estimated $430K.
- 28 institutional investors held Microbot Medical (MBOT) as of Q2 2023, down from 29 in Q1 2023.
- Funds reported $3.36M of Microbot Medical stock for Q2 2023, up 14% quarter-over-quarter.
- 4 funds opened new Microbot Medical positions in Q2 2023 and 5 closed out, a net change of -1 holder.
- The largest Microbot Medical buyer in Q2 2023 was Renaissance Technologies, an estimated $135K added.
- The largest Microbot Medical seller in Q2 2023 was Armistice Capital, an estimated $430K sold.
Based on aggregated 13F filings for Q2 2023.